A study from Saudi Arabia found that no major side effects were associated with AstraZeneca's COVID-19 vaccine AZD1222 and no breakthrough infections were seen, Arab News reported.

The analysis included 1592 randomly selected people who received the vaccine, with results showing that 34.7% reported a reaction after the first dose, while none had a reaction after the second.
The side effects included injection site pain in 30.5% of subjects and musculoskeletal symptoms in 27.5%.
The study also concluded that the rate of post-vaccine COVID-19 infection was 0.5% with zero hospitalisations.










(All Rights Reserved)